BR112021018890A2 - Composição para sustentar a função cerebral saudável - Google Patents

Composição para sustentar a função cerebral saudável

Info

Publication number
BR112021018890A2
BR112021018890A2 BR112021018890A BR112021018890A BR112021018890A2 BR 112021018890 A2 BR112021018890 A2 BR 112021018890A2 BR 112021018890 A BR112021018890 A BR 112021018890A BR 112021018890 A BR112021018890 A BR 112021018890A BR 112021018890 A2 BR112021018890 A2 BR 112021018890A2
Authority
BR
Brazil
Prior art keywords
composition
brain function
healthy brain
support healthy
fermentate
Prior art date
Application number
BR112021018890A
Other languages
English (en)
Inventor
Arvind Venkataraman
Lynn Brewster Chelsay
Conner Kozak Kimberly
Lijuan Li
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR112021018890A2 publication Critical patent/BR112021018890A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composição para sustentar a função cerebral saudável. é descrita, no presente documento, uma composição contendo bactérias probióticas e um fermentado que pode aumentar a produção de ipa. a composição compreende uma ou mais bactérias tendo uma sequência de ácidos nucleicos com ao menos 80% de homologia com a sequência de ácidos nucleicos da seq id no: 1, um fermentado que compreende farinha de soja, uma levedura e uma enzima proteolítica, e um excipiente, veículo e/ou diluente. a composição pode promover a saúde cerebral e/ou a função do sistema nervoso.
BR112021018890A 2019-04-02 2020-04-02 Composição para sustentar a função cerebral saudável BR112021018890A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962827994P 2019-04-02 2019-04-02
PCT/US2020/026280 WO2020206050A1 (en) 2019-04-02 2020-04-02 Composition to support healthy brain function

Publications (1)

Publication Number Publication Date
BR112021018890A2 true BR112021018890A2 (pt) 2021-12-14

Family

ID=70471100

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021018890A BR112021018890A2 (pt) 2019-04-02 2020-04-02 Composição para sustentar a função cerebral saudável

Country Status (8)

Country Link
US (1) US20200316141A1 (pt)
EP (1) EP3947635A1 (pt)
CN (1) CN113661237A (pt)
AU (1) AU2020252361A1 (pt)
BR (1) BR112021018890A2 (pt)
CA (1) CA3135621A1 (pt)
MX (1) MX2021011309A (pt)
WO (1) WO2020206050A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116173075A (zh) * 2022-10-17 2023-05-30 西北农林科技大学 一种基于生孢梭菌改善认知功能的合生元组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977004A (en) 1987-09-28 1990-12-11 Tropicana Products, Inc. Barrier structure for food packages
US6524720B1 (en) 1992-09-18 2003-02-25 Cryovac, Inc. Moisture barrier film
US6130263A (en) 1995-04-19 2000-10-10 Capitol Specialty Plastics, Inc. Desiccant entrained polymer
GB9517106D0 (en) 1995-08-21 1995-10-25 Bp Chem Int Ltd Polymer blends
US6274210B1 (en) 1995-12-15 2001-08-14 W. R. Grace & Co. -Conn Oxygen scavenging compositions with low migration
US6387461B1 (en) 1999-05-06 2002-05-14 Cryovac, Inc. Oxygen scavenger compositions
US6716499B1 (en) 2000-06-08 2004-04-06 Cryovac, Inc. Moisture/oxygen barrier bag
US6806069B2 (en) * 2001-01-09 2004-10-19 Pharmachem Laboratories, Inc. Ubiquinone composition and methods related thereto
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US6746622B2 (en) 2002-02-08 2004-06-08 Chevron Phillips Chemical Company Lp Oxygen scavenging compositions comprising polymers derived from tetrahydrofurfuryl monomers
US9744155B2 (en) * 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
WO2018136884A1 (en) * 2017-01-23 2018-07-26 The Regents Of The University Of California Compositions and methods for treating obesity and inducing weight loss

Also Published As

Publication number Publication date
EP3947635A1 (en) 2022-02-09
US20200316141A1 (en) 2020-10-08
WO2020206050A1 (en) 2020-10-08
CN113661237A (zh) 2021-11-16
MX2021011309A (es) 2021-10-22
AU2020252361A1 (en) 2021-10-14
CA3135621A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
BR112013026114A2 (pt) composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas
MY197900A (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
MX2020003198A (es) Bacterias acidolácticas novedosas y uso de las mismas.
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
HUP0200205A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
BR112012013571A2 (pt) composições alimentares para animais de estimação,incluindo probióticos e os métodos de fabricação e á sua uitlização.
BR0207749A (pt) Bactérias do ácido láctico como agentes para tratar e prevenir alergias
BRPI0414722A (pt) meios sem produto animal e processos para obtenção de uma toxina botulìnica
HUP0200206A2 (hu) Tejsavbaktérium-törzsek hasmenés megelőzésére
BR112016017534A2 (pt) proteína
BR112022022524A2 (pt) Proteínas imunomoduladoras inibidoras de april e baff com e sem uma proteína inibidora de células t e métodos de uso das mesmas
BR112016000658A2 (pt) pancreatina de alta atividade, processo para a preparação de pancreatina de aa tendo atividade lipásica específica de pelo menos aproximadamente 120 usp iu/mg e método de tratamento de um paciente sujeito a uma condição patológica associada com a insuficiência enzimática pandreática
BR112021018890A2 (pt) Composição para sustentar a função cerebral saudável
BR112012018385A2 (pt) indução e estabilização de atividade enzimática em micro-organismos
BR0114105A (pt) Bactérias de acido lático capazes de reduzir uma tendência do indivìduo para desenvolver reações alérgicas
Solanki et al. Prevalence and risk factors of nocturnal enuresis among school age children in rural areas
BR112018011954A2 (pt) formulação líquida de enzima, método para produzir uma formulação líquida de enzima, e, uso de uma formulação líquida de enzima.
GB0202556D0 (en) Novel Protein
WO2020008149A8 (fr) Utilisation d'une souche de roseburia intestinalis pour la prévention et le traitement de l'inflammation de l'intestin
WO2016100820A3 (en) Fgf2 truncations and mutants and uses thereof
BR0011186A (pt) Protease, seu gene e seus usos
Sengupta The emergence of the menopause in India
Sandionigi et al. Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu‐Vaccinated Healthy Elderly Subjects
BR0015102A (pt) Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase
Aguayo et al. Taste preference and psychopathology

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2737 DE 20-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.